SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0000950103-23-013705
Filing Date
2023-09-18
Accepted
2023-09-18 17:30:22
Documents
13
Period of Report
2023-09-18
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K dp200201_8k.htm   iXBRL 8-K 30691
2 EXHIBIT 99.1 dp200201_ex9901.htm EX-99.1 8277
  Complete submission text file 0000950103-23-013705.txt   217439

Data Files

Seq Description Document Type Size
3 XBRL SCHEMA FILE bhc-20230918.xsd EX-101.SCH 3024
4 XBRL LABEL FILE bhc-20230918_lab.xml EX-101.LAB 34240
5 XBRL PRESENTATION FILE bhc-20230918_pre.xml EX-101.PRE 22366
7 EXTRACTED XBRL INSTANCE DOCUMENT dp200201_8k_htm.xml XML 3317
Mailing Address 2150 ST. ELZEAR BLVD. WEST LAVAL QUEBEC A8 H7L 4A8
Business Address 2150 ST. ELZEAR BLVD. WEST LAVAL QUEBEC A8 H7L 4A8 514-744-6792
Bausch Health Companies Inc. (Filer) CIK: 0000885590 (see all company filings)

IRS No.: 000000000 | State of Incorp.: NJ | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-14956 | Film No.: 231261964
SIC: 2834 Pharmaceutical Preparations